Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal
Conclusion: In patients with severe AW who require sedation, both dexmedetomidine and propofol have unique and advantageous properties. Both agents appear to have equivalent efficacy in reducing AW-related symptoms and benzodiazepine and haloperidol requirements. These results should be validated in a larger, prospective trial. Keywords: dexmedetomidine, propofol, benzodiazepines, alcohol, withdrawal
Source: International Journal of COPD - Category: Respiratory Medicine Tags: Clinical Pharmacology: Advances and Applications Source Type: research
More News: Alcoholism | Chronic Obstructive Pulmonary | Diprivan | Drugs & Pharmacology | Intensive Care | Propofol | Respiratory Medicine | Study | Toxicology